Google ile giriş. Kart gerekmez.
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Reporting to the Head of Global Commercial Development, this leader will build and lead Global Analytics & Insights across Disease Area Insights, Forecasting, and Data & Analytics. The role directly manages the functional leads and sets strategy, priorities and standards across the product lifecycle, from preclinical and Phase 1 assets through commercialization.
The Vice President will connect insights and analytics to development, portfolio and commercial decisions; develop senior leaders; and align resources with business priorities. Working across functions and regions, this leader will maintain an integrated view of the external environment and tailor global support to regional capabilities and needs. The role combines strategic leadership and functional excellence with direct contributions to critical business questions as the organization grows. This position is based at our headquarters in Redwood City, CA.
Responsibilities
-
Set and execute the global A&I strategy, aligning priorities, capabilities and resources across early products, later-stage programs and commercial assets. Anticipate evolving business needs and scale support for an expanding portfolio and geographic footprint. Establish an integrated learning and analytics agenda across the three functions, aligning evidence generation and delivery with major business decisions and planning milestones.
-
Directly manage, coach and develop the functional leads for Disease Area Insights, Forecasting, and Data & Analytics. Establish clear accountabilities, objectives and expectations for delivery, enabling leaders to build specialized expertise and effective teams.
-
Oversee an integrated Disease Area Insights capability combining competitive intelligence and market insights. Ensure teams assess the external environment, identify unmet needs and market gaps, and evaluate strategic options to inform choices within disease areas and across the portfolio.
-
Maintain an integrated company-wide view of markets and competition, drawing together disease area findings and cross-functional perspectives. Ensure external developments are translated into timely implications for the broader portfolio.
-
Connect insights, forecasting and analytics to lead cross-portfolio scenario planning and integrate the A&I recommendation for the relevant business decision makers. Assess the implications of emerging developments, evolving treatment practices and overlapping products and indications, and advise senior leadership on opportunities, risks and strategic responses. Provide independent, evidence-based challenge to internal assumptions and investment cases and elevate material disagreements and uncertainty.
-
Oversee global revenue forecasting and analytical support for long-range planning, supply and investment decisions. Integrate regional inputs and promote shared frameworks with clearly understood assumptions and differences. Agree forecast ownership, review and approval responsibilities with Finance, Supply Chain and regional leaders for each planning purpose.
-
Partner with Commercial, Medical Affairs, Research, Clinical Development, Market